The Durable Safety and Effectiveness of Lixisenatide in Japanese People with Type 2 Diabetes: The Post-Marketing Surveillance PRANDIAL Study
Crossref DOI link: https://doi.org/10.1007/s12325-022-02121-5
Published Online: 2022-04-21
Published Print: 2022-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Terauchi, Yasuo
Usami, Makiko
Inoue, Tomoyuki
Funding for this research was provided by:
Sanofi K.K.
Text and Data Mining valid from 2022-04-21
Version of Record valid from 2022-04-21
Article History
Received: 16 December 2021
Accepted: 9 March 2022
First Online: 21 April 2022